“Investigation of plasminogen activator inhibitor-1 (PAI-1) levels in patients diagnosed with polycystic ovary syndrome”, Aegean J Obstet Gynecol, vol. 3, no. 1, pp. 6–9, Apr. 2021, doi: 10.46328/aejog.v3i1.79.